Z5112 - Encounter for antineoplastic immunotherapy

Assigns to MDC 17

One MDC, with the conditional pathways below listed separately.

MDC 17 Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms

Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures

826 827 828

MDC 17 Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms

Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures

829 830

MDC 17 Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms

Chemotherapy with Acute Leukemia as Secondary Diagnosis or with High Dose Chemotherapy Agent

837 838 839

MDC 17 Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms

Chemotherapy without Acute Leukemia as Secondary Diagnosis

846 847 848

Enter Z5112 as the principal diagnosis to see the DRG and its relative weight.